Complete List of Androgen biosynthesis inhibitor Medicines
Brand: ABREMIA |
Strength: 250 mg |
Form: Tablets
Class: | Antineoplastic agent, androgen biosynthesis inhibitor
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone
Adult dose: | 1000 mg (fou...
Brand: CYPROST |
Strength: 250 mg |
Form: Tablets
Class: | Antineoplastic agent, androgen biosynthesis inhibitor
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone or prednisolone
Adult dose...
Brand: CYPROST |
Strength: 500 mg |
Form: Tablets
Class: | Antineoplastic agent, androgen biosynthesis inhibitor
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate canc...
Brand: TEROPROS |
Strength: 500 mg |
Form: Tablets
Class: | Antineoplastic agent, androgen biosynthesis inhibitor
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC), often in combination with prednisone
Adult dose: | 1000 ...
Brand: TIGATRON |
Strength: 250 mg |
Form: Tablets
Class: | Hormonal Antineoplastic Agent (Androgen Biosynthesis Inhibitor)
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone
Adult dose: | 10...
Brand: ZYTIGA |
Strength: 250 mg |
Form: Tablets
Class: | Antineoplastic agent, androgen biosynthesis inhibitor
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone; also indicated for treatmen...
Brand: ZYTIGA |
Strength: 250 mg |
Form: Tablets
Class: | Antineoplastic agent, androgen biosynthesis inhibitor
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone; also indicated for high-ris...
Brand: ZYTIGA |
Strength: 500 mg |
Form: Tablets
Class: | Antineoplastic agent, androgen biosynthesis inhibitor
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone; also indicated for high-ris...
Brand: ZYTIGA |
Strength: 500 mg |
Form: Tablets
Class: | Antineoplastic agent, androgen biosynthesis inhibitor
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone; also indicated for high-ris...
Brand: AKEEGA |
Strength: 100 mg,500 mg |
Form: Film Coated Tablets
**NIRAPARIB**
Class: | PARP inhibitor
Use: | Treatment of patients with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy.
Adult dose: | Initial dos...
Brand: AKEEGA |
Strength: 50 mg,500 mg |
Form: Film Coated Tablets
**NIRAPARIB**
Class: | PARP inhibitor
Use: | Treatment of patients with recurrent ovarian cancer who have responded to platinum-based chemotherapy; also used in certain breast cancers with BRCA mu...